Peng Wei-Na, Wang Lin, Liu Zhi-Shun, Guo Jun, Cai Heng-Jing, Ni Jing-Nian, Duan Jin-Xiu, Yang De-Li
Department of Acupuncture and Moxibustion, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Department of Acupuncture and Moxibustion, Beijing Huguosi Hospital of TCM.
Zhongguo Zhen Jiu. 2013 Oct;33(10):865-9.
To evaluate the follow-up efficacy and safety on slow transit constipation (STC) treated with individualized deep puncture at Tianshu (ST 25).
One hundred and twenty-eight cases of STC were randomized into a deep puncture group (64 cases), a western medication group (31 cases) and a shallow puncture group (33 cases) at the ratio of 2:1:1. In the deep puncture group, electroacupuncture of deep puncture was applied to bilateral Tianshu (ST 25). The needle was inserted perpendicularly and slowly at the acupoint and went deeply till penetrating the peritoneum, about 20 to 65 mm in depth. In the western medication group, lactulose oral liquid was prescribed for oral administration. In the shallow puncture group, electroacupuncture of shallow puncture was done at bilateral Tianshu (ST 25). The needle was inserted perpendicularly and slowly, 5 to 8 mm in depth. The treatment lasted 4 weeks in the three groups and the follow-up visit of 12 weeks and 6 month after treatment was performed respectively. The weekly defecation frequency, patient's satisfaction and safety of deep puncture at Tianshu (ST 25) were assessed before and after treatment in each group.
In the deep puncture group, the weekly defecation frequency was (1.79 +/- 1.05) times/week before treatment and was (3.90 +/- 1.43) times/week after 4-week treatment. It was (3.49 +/- 1.46) times/week in 12-week follow-up visit after treatment and was (3.51 +/- 1.42) times/week in 6-month follow-up visit after treatment. In the deep puncture group, the improvements in weekly defecation frequency, patient's satisfaction and short-term efficacy were same as those in the western medication group and the shallow puncture group (all P > 0.05). The long-term efficacy in follow-up visit was better remarkably than that in the western medication group (P < 0.05, P < 0.01). Besides, the combined medication was reduced and no adverse reaction occurred.
The individualized deep puncture at Tianshu (ST 25) is effective in the treatment of STC and achieves the satisfactory long-term efficacy. This therapy displays the good effective advantage and deserves to be promoted in clinical practice of acupuncture and moxibustion therapeutic program as compared with the first-tier line of medication, lactulose oral liquid, recommended at home and abroad, in terms of the evidence-based medicine.
评价天枢(ST25)个体化深刺治疗慢传输型便秘(STC)的随访疗效及安全性。
将128例STC患者按2∶1∶1的比例随机分为深刺组(64例)、西药组(31例)和浅刺组(33例)。深刺组采用深刺电针双侧天枢(ST25),穴位垂直缓慢进针,深度达穿透腹膜,约20~65mm;西药组口服乳果糖口服液;浅刺组采用浅刺电针双侧天枢(ST25),垂直缓慢进针,深度5~8mm。三组治疗均持续4周,分别于治疗后12周和6个月进行随访。评估每组治疗前后每周排便次数、患者满意度及天枢(ST25)深刺的安全性。
深刺组治疗前每周排便次数为(1.79±1.05)次/周,治疗4周后为(3.90±1.43)次/周,治疗后12周随访为(3.49±1.46)次/周,治疗后6个月随访为(3.51±1.42)次/周。深刺组每周排便次数、患者满意度及近期疗效改善情况与西药组和浅刺组相当(均P>0.05),随访远期疗效明显优于西药组(P<0.05,P<0.01)。此外,联合用药减少,未出现不良反应。
天枢(ST25)个体化深刺治疗STC有效,远期疗效满意。与国内外推荐的一线用药乳果糖口服液相比,该疗法显示出良好的疗效优势,值得在针灸治疗方案的临床实践中推广应用。